Published in Malar J on August 10, 2011
Adherence to chemoprophylaxis and Plasmodium falciparum anti-circumsporozoite seroconversion in a prospective cohort study of Dutch short-term travelers. PLoS One (2013) 0.81
The epidemiology of imported malaria in Taiwan between 2002-2013: the importance of sensitive surveillance and implications for pre-travel medical advice. Int J Environ Res Public Health (2014) 0.80
Environmental determinant of malaria cases among travellers. Malar J (2013) 0.77
A comparison of compliance rates with anti-vectorial protective measures during travel to regions with dengue or chikungunya activity, and regions endemic for Plasmodium falciparum malaria. J Travel Med (2016) 0.76
Factors associated with malaria chemoprophylaxis compliance among French service members deployed in Central African Republic. Malar J (2016) 0.75
The impact of confounder selection criteria on effect estimation. Am J Epidemiol (1989) 13.34
A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol (1976) 11.56
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS (1999) 4.39
Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes. Am J Epidemiol (1998) 3.66
The Health Belief Model and prediction of dietary compliance: a field experiment. J Health Soc Behav (1977) 2.73
A malaria outbreak following a British military deployment to Sierra Leone. J Infect (2003) 2.05
Malaria in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis (2004) 1.80
Clinical practice. Malaria prevention in short-term travelers. N Engl J Med (2008) 1.75
Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and Thailand. J Travel Med (2008) 1.62
Malaria risk perception, knowledge and prophylaxis practices among travellers of African ethnicity living in Paris and visiting their country of origin in sub-Saharan Africa. Trans R Soc Trop Med Hyg (2007) 1.53
Knowledge of malaria, risk perception, and compliance with prophylaxis and personal and environmental preventive measures in travelers exiting Zimbabwe from Harare and Victoria Falls International airport. J Travel Med (2001) 1.25
Health and equity impacts of a large oil project in Africa. Bull World Health Organ (2003) 1.07
Compliance with malaria chemoprophylaxis and preventative measures against mosquito bites among Dutch travellers. Trop Med Int Health (1997) 1.05
Cognitive predictors of adherence to malaria prophylaxis regimens on return from a malarious region: a prospective study. Soc Sci Med (1999) 1.05
The genetics of sleep disorders. Lancet Neurol (2002) 1.02
Chemoprophylaxis compliance in a French battalion after returning from malaria-endemic area. J Travel Med (2008) 1.02
Knowledge, attitudes, and practices among foreign backpackers toward malaria risk in southeast Asia. J Travel Med (2009) 1.01
Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes Metab (2006) 1.00
Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa. Malar J (2010) 0.98
Outbreak of malaria among policemen in French Guiana. Mil Med (2007) 0.95
Risk of malaria among French adult travellers. Travel Med Infect Dis (2005) 0.94
Health beliefs and communication in the travel clinic consultation as predictors of adherence to malaria chemoprophylaxis. Br J Health Psychol (2004) 0.91
Malaria--a major health problem within an oil palm plantation around Popondetta, Papua New Guinea. Malar J (2009) 0.88
Use of medical chemoprophylaxis and antimosquito precautions in Danish malaria patients and their traveling companions. J Travel Med (2001) 0.87
Remote sensing and malaria risk for military personnel in Africa. J Travel Med (2008) 0.86
The influence of age, work schedule and personality on morningness dimension. Int J Psychophysiol (1992) 0.83
Travelers' compliance to prophylactic measures and behavior during stay abroad: results of a retrospective study of subjects returning to a travel medicine center in Italy. J Travel Med (2006) 0.82
Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis (2011) 7.42
Combination of malaria vector control interventions in pyrethroid resistance area in Benin: a cluster randomised controlled trial. Lancet Infect Dis (2012) 4.44
Prognostic value of thrombocytopenia in African children with falciparum malaria. Am J Trop Med Hyg (2002) 3.78
Protective efficacy of lambda-cyhalothrin treated nets in Anopheles gambiae pyrethroid resistance areas of Côte d'Ivoire. Am J Trop Med Hyg (2005) 2.89
Incidence of tick-borne relapsing fever in west Africa: longitudinal study. Lancet (2006) 2.77
Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markers. Malar J (2009) 2.76
Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination. Malar J (2010) 2.75
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med (2007) 2.54
Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. Am J Trop Med Hyg (2006) 2.34
Recombinant human erythropoietin prevents the death of mice during cerebral malaria. J Infect Dis (2006) 2.06
Combating malaria in Africa. Trends Parasitol (2002) 1.98
Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Am J Trop Med Hyg (2006) 1.97
Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors. PLoS Negl Trop Dis (2010) 1.89
Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo. J Clin Microbiol (2006) 1.74
Highly focused anopheline breeding sites and malaria transmission in Dakar. Malar J (2009) 1.63
Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa. Microbes Infect (2007) 1.63
Vivax malaria in Mauritania includes infection of a Duffy-negative individual. Malar J (2011) 1.63
Malaria infection and disease in an area with pyrethroid-resistant vectors in southern Benin. Malar J (2010) 1.59
Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrob Agents Chemother (2009) 1.59
Social and environmental malaria risk factors in urban areas of Ouagadougou, Burkina Faso. Malar J (2009) 1.57
Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006. Am J Trop Med Hyg (2007) 1.55
Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One (2007) 1.44
Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs. Malar J (2011) 1.40
Circulation of Chikungunya virus in Gabon, 2006-2007. J Med Virol (2008) 1.40
Implication of haematophagous arthropod salivary proteins in host-vector interactions. Parasit Vectors (2011) 1.39
Malaria transmission in Dakar: a two-year survey. Malar J (2008) 1.38
Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials (2003) 1.36
An epidemiologic model of the incidence of acute illness in Plasmodium falciparum malaria. Am J Trop Med Hyg (2006) 1.35
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum. Antimicrob Agents Chemother (2007) 1.33
Changing malaria epidemiology and diagnostic criteria for Plasmodium falciparum clinical malaria. PLoS One (2012) 1.33
Comparative performances, under laboratory conditions, of seven pyrethroid insecticides used for impregnation of mosquito nets. Bull World Health Organ (2003) 1.33
Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal. Malar J (2010) 1.31
Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline. Antimicrob Agents Chemother (2008) 1.29
Genetic structure of Plasmodium falciparum and elimination of malaria, Comoros archipelago. Emerg Infect Dis (2010) 1.27
Spatial heterogeneity and temporal evolution of malaria transmission risk in Dakar, Senegal, according to remotely sensed environmental data. Malar J (2010) 1.25
Malaria incidence in relation to rice cultivation in the irrigated Sahel of Mali. Acta Trop (2004) 1.25
Molecular detection of Bartonella quintana, B. Elizabethae, B. Koehlerae, B. Doshiae, B. Taylorii, and Rickettsia felis in rodent fleas collected in Kabul, Afghanistan. Am J Trop Med Hyg (2006) 1.24
Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests. Malar J (2013) 1.23
Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers. J Antimicrob Chemother (2005) 1.23
Possible autochthonous malaria from Marseille to Minneapolis. Emerg Infect Dis (2007) 1.22
The use of remotely sensed environmental data in the study of malaria. Geospat Health (2011) 1.22
Genetic determination and linkage mapping of Plasmodium falciparum malaria related traits in Senegal. PLoS One (2008) 1.20
Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania. J Antimicrob Chemother (2011) 1.19
Rickettsia species in African Anopheles mosquitoes. PLoS One (2012) 1.19
Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali. Malar J (2010) 1.19
Utilization of combined remote sensing techniques to detect environmental variables influencing malaria vector densities in rural West Africa. Int J Health Geogr (2012) 1.18
Susceptibility of Plasmodium falciparum isolates to doxycycline is associated with pftetQ sequence polymorphisms and pftetQ and pfmdt copy numbers. J Infect Dis (2010) 1.18
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool. Antimicrob Agents Chemother (2013) 1.15
Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers. Am J Trop Med Hyg (2006) 1.13
Artesunate tolerance in transgenic Plasmodium falciparum parasites overexpressing a tryptophan-rich protein. Antimicrob Agents Chemother (2011) 1.12
Quinine-resistant malaria in traveler returning from Senegal, 2007. Emerg Infect Dis (2010) 1.11
A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens. Malar J (2010) 1.11
In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs. Antimicrob Agents Chemother (2011) 1.10
Diagnostic criteria and risk factors for Plasmodium ovale malaria. J Infect Dis (2002) 1.10
Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum. Antimicrob Agents Chemother (2010) 1.10
Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria. Antimicrob Agents Chemother (2009) 1.10
Malaria prevalence and morbidity among children reporting at health facilities in Nouakchott, Mauritania. Trans R Soc Trop Med Hyg (2011) 1.10
Antimalarial drug use in general populations of tropical Africa. Malar J (2008) 1.09
Chloroquine resistance reversal agents as promising antimalarial drugs. Curr Drug Targets (2006) 1.09
Conditions of malaria transmission in Dakar from 2007 to 2010. Malar J (2011) 1.08
In vitro activity of tafenoquine against the asexual blood stages of Plasmodium falciparum isolates from Gabon, Senegal, and Djibouti. Antimicrob Agents Chemother (2006) 1.08